ISO announced plans to acquire the assets of Urix, a provider of healthcare analytics and employer reporting solutions. Terms have not been disclosed. Urix has developed Web-based business solutions that enable health insurers, national brokerage firms, and large employers to derive strategies to improve the quality of healthcare while lowering the cost of delivery.

ISO entered the healthcare sector in 2004 with the purchase of Boston-based DxCG, a predictive modeling software developer. ISO will form a single company containing the Urix and DxCG assets doing business under the Urix brand name. John J. Farrell, CEO of Urix, will serve as president of the combined entity; Michael Coyne will serve as chief operating officer.

"With so many synergies between the Urix business intelligence solutions and DxCG predictive modeling capabilities, it makes sense to combine our assets and approach the market with a unified set of solutions," says Coyne, head of DxCG.

Farrell praised the combination, noting ISO's resources and strong reputation for leadership in analytics and data management will help Urix broaden its health analytics toolset. "For Urix, this will mean a limitless opportunity to enhance further the power of our rapidly growing health data analytics services," says Farrell.

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
  • Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.